New Data from SLN124 Healthy Volunteer Study Reinforce

New Data from SLN124 Healthy Volunteer Study Reinforce Broad Therapeutic Potential in Hematological Diseases Data presented at 2021 ASH annual meeting...

Related Keywords

London ,City Of ,United Kingdom ,United States ,American ,Giles Campion ,Mary Conway ,Hansoh Pharma ,John Porter ,University College London ,University Of College London Hospitals ,Mallinckrodt Pharmaceuticals ,Nasdaq ,American Society Of Hematology ,Astrazeneca ,Corporate Communications ,Head Of Research Development At Silence ,Consilium Strategic Communications ,New Data ,Silence Therapeutics ,Annual Meeting ,Chief Medical Officer ,Consultant Hematologist ,Red Cell Disorders Unit ,College London Hospitals ,Orphan Drug Designation ,Angela Gray ,Myelodysplastic Syndrome ,Polycythemia Vera ,London Stock Exchange Sln ,Silence Therapeutics Plc ,